GlassScriptPhysician profile
Steven J Dibiase
NPI 1750332292
$17,141.27
in general payments reported to CMS, 2019-2025
9 companies · $734 in 2025
The $734 reported for 2025 was more than what 80% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,620 · 2020: $5,946 · 2021: $428 · 2022: $537 · 2023: $748 · 2024: $130 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.06 |
| Travel and Lodging | $296.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $12,840.31 | 2019-2020 | |
| Sirtex Medical INC | $1,935.82 | 2019-2023 | Sir-Spheres Microspheres |
| Novocure INC. | $1,100.31 | 2019-2025 | Optune, Optune Gio |
| Siemens Medical Solutions USA, INC. | $862.97 | 2023-2025 | Varian Ethos Treatment Planning, Truebeam |
| Trisalus Life Sciences, INC. | $221.97 | 2022 | |
| Gt Medical Technologies, INC | $122.48 | 2022 | |
| Genzyme Corporation | $23.82 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $20.83 | 2019 | |
| Angiodynamics, INC. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Dibiase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.